Biogen Inc.
BIIB Healthcare Drug Manufacturers General
Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow BIIB
Biogen Inc. (BIIB) Revenue growth
Biogen Inc.'s revenue growth over the twelve months to 30 June 2026 was 0.31%, down 1.9 percentage points from fiscal 2025 (2.22%). Over the past ten years it has ranged from −18.3% (fiscal 2021) to 10.9% (fiscal 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers General industry median of 6.66% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 2.22% | 3.84 |
| FY2024 | −1.62% | 1.70 |
| FY2023 | −3.32% | 4.04 |
| FY2022 | −7.36% | 10.96 |
| FY2021 | −18.3% | (11.83) |
| FY2020 | −6.49% | (13.37) |
| FY2019 | 6.88% | (2.73) |
| FY2018 | 9.61% | 2.40 |
| FY2017 | 7.21% | 0.85 |
| FY2016 | 6.36% | (4.57) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 3.42% | 1.49 |
| Mar 2026 | 1.93% | 9.07 |
| Dec 2025 | −7.14% | (9.93) |
| Sep 2025 | 2.79% | (4.54) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| SNY Sanofi compare | 21.3% |
| NVO Novo Nordisk A/S compare | 13.2% |
| AMGN Amgen Inc. compare | 9.10% |
| GSK GSK PLC Sponsored ADR compare | 8.72% |
| AZN AstraZeneca PLC compare | 8.61% |
| GILD Gilead Sciences, Inc. compare | 5.52% |
| BMY Bristol Myers Squibb Company compare | 3.11% |
| BIIB Biogen Inc. | 0.31% |
| PFE Pfizer Inc. compare | −0.21% |
| Drug Manufacturers General industry median | 6.66% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BIIB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement